Wieder-Huszla et al. assessing cytokine levels in patients with ovarian cancer and endometrial cancer, found that IL-4 levels were higher in the group of patients with ovarian cancer than in those with endometrial cancer. This evidence concerns the gene IL4 and endometrial cancer.